Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07571538

VisionApp - Ghosting

Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to ghosting vision.

VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Recruiting

Interested in participating?

Request Info

Key information

Age range

8 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Optics Research Lab

Bloomington, Indiana, 47405, United States

Location status: Recruiting

Location contact

Pete Kollbaum, PhD

CONTACT

[email protected]

About this study

Subjects will be enrolled at the Clinical Optics Research Lab at Indiana University.

At the study visit, demographic and health/ocular history may be collected by oral history and standard clinical testing including refraction (check of glasses prescription), auto-refraction or abbrerometry may be performed. Visual acuity and room lighting checks may also be measured using standard clinical techniques.

For the experimental portion of the study visit, participants will be asked to look at letters and describe any shadows or distortions they see using slider bars or numerical rating scales, while wearing different contact lenses. Participants will first be asked to wear commercially available single vision contact lenses to establish best corrected vision. A single vision lens will then remain in one eye, and participants will proceed with ghosting assessments using two different multifocal contact lenses worn in the other eye. Adult participants will perform the ghosting assessments while wearing 2 commercially available multifocal lenses, and children participants will perform the ghosting assessments while wearing a commercially available and investigational lens. Randomization will determine which lens is worn first.

If participants are unable to complete all testing in a single session, they may be permitted to return on a subsequent day.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • has a refractive error between Plano and -5.00 D of sphere and cylinder components combined.
  • has refractive cylinder (e.g., astigmatism) of -0.75 D or less
  • has had a self-reported oculo-visual exam in the last 2 years
  • has best-corrected visual acuity of at least 20/20 in each eye
  • is not amblyopic or does not have any diagnosed ocular disease
  • is willing and able to follow instructions and maintain the appointment schedule

Exclusion criteria

  • has any systemic disease affecting ocular health and visual acuity
  • is currently using any systemic or topical medications that could affect ocular health and visual acuity
  • is participating in another eye related research study

Treatment and study plan

Proclear 1 Day Contact Lens

Device

Proclear 1 day is a commercially available single vision soft contact lens for single use (daily wear). Participants will wear these contacts at the beginning of the study visit to establish best corrected vision. Participants will then continue to wear this contact lens in one eye for the duration of the study visit.

MyDay Contact Lens

Device

MyDay is a commercially available multifocal soft contact lens for daily wear. Adult participants will assess images for ghosting while wearing a MyDay contact lens in one eye. Order of exposure to this lens will be determined via randomization.

NaturalVue Contact Lens

Device

NaturalVue is a commercially available multifocal soft contact lens for daily wear. Adult participants will assess images for ghosting while wearing a NaturalVue contact lens in one eye. Order of exposure to this lens will be determined via randomization.

MiSight 1 Day contact lens

Device

MiSight 1 Day is a commercially available multifocal soft contact lens for daily wear. Children participants will assess images for ghosting while wearing a MiSight 1 Day contact lens in one eye. Order of exposure to this lens will be determined via randomization.

Investigational Contact Lens

Device

An investigational multifocal soft contact lens for daily wear. While the contact lens is made of an FDA approved material which is already marketed in the United States, it differs from commercially available lenses in that it has a slightly different optical design. Children participants will assess images for ghosting while wearing this investigational contact lens in one eye. Order of exposure to this lens will be determined via randomization.

VisionApp

Device

VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc.)

Primary outcomes

  1. Ghosting Quantification

    Time frame: Day 1

    Ghosting quantification (e.g. how "doubled" the image looks) will be compared against expected template images and those predicted.

    Subjects will provide a quality rating of ghosting on a scale between 0 - 100, with lower scores indicating more ghosting of the image and 100 representing an optically perfect image. The VisionApp will also model ghosting measurements for direction, separation, blur and strength into a predictive quality rating, which will be compared to the subject's subjective expected, or overall, quality rating.

Study contacts

Contact information is provided by the study sponsor or research team.

Pete Kollbaum, PhD

CONTACT

[email protected]

812-555-5500

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Official study title

Assessment of the Accuracy and Repeatability of the VisionApp - Ghosting Measurement Protocol

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 6, 2026
Registry last updated
May 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.